At ESMO 2023, the results of the Papillon study, a phase 3 trial comparing...
Until now, a single TKI has been the standard treatment in patients with...
Prof emeritus Johan Vansteenkiste discusses the outcomes of the MARIPOSA2 trial...
Prof Patrick Neven, a distinguished gynaecological oncologist affiliated with...
Dr Philippe Aftimos, medical oncologist at Jules Bordet Institut Brussels,...
Professor Christine Gennigens, a distinguished medical oncologist at CHU de...
Dr Mariana Brandão, medical oncologist at Jules Bordet Institut Brussels,...
Prof Christine Gennigens, a medical oncologist at CHU de Liège, conducted an...
Dr Mariana Brandao, a medical oncologist at the Clinic of Thoracic Oncology at...
Dr Elena Benidovskaya, researcher at the Université Catholique de Louvain,...